Recent Study: Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013

Fast Market Research recommends "Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013" from Global Markets Direct, now available


Boston, MA -- (SBWire) -- 01/27/2014 --Global Market Direct's pharmaceuticals report, "Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2013" provides data on the Collegium Pharmaceutical, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Collegium Pharmaceutical, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Collegium Pharmaceutical, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Collegium Pharmaceutical, Inc. - Brief Collegium Pharmaceutical, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Collegium Pharmaceutical, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Collegium Pharmaceutical, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Collegium Pharmaceutical, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Collegium Pharmaceutical, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Collegium Pharmaceutical, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Collegium Pharmaceutical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Collegium Pharmaceutical, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Collegium Pharmaceutical, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Collegium Pharmaceutical, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Chugai Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Simcere Pharmaceutical Group - Product Pipeline Review - 2013
- Mochida Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2013
- La Jolla Pharmaceutical Company - Product Pipeline Review - 2013
- Chong Kun Dang Pharmaceutical Corp. - Product Pipeline Review - 2013
- Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013

Media Relations Contact

Bill Thompson
Director of Marketing

View this press release online at: